Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
about
Recovery of endocrine function after islet and pancreas transplantationSUITO index for evaluation of clinical islet transplantation.Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.Arginine is preferred to glucagon for stimulation testing of β-cell function.Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockadeCluster analysis of self-monitoring blood glucose assessments in clinical islet cell transplantation for type 1 diabetesDetailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function.Pancreatic islet cell transplantation: update and new developments.The clinical utility of C-peptide measurement in the care of patients with diabetesValidation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept.A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes.Effect of exenatide on gastric emptying and graft survival in islet allograft recipientsLong-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States.Early metabolic markers of islet allograft dysfunction.Impact of islet transplantation on glycemic control as evidenced by a continuous glucose monitoring system.Ileal interposition and viability of pancreatic islets transplanted into intramuscular site of diabetic rats.Beta-5 score to evaluate pig islet graft function in a primate pre-clinical model.Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.SUITO index for evaluation of efficacy of single donor islet transplantation.Multicenter Assessment of Animal-free Collagenase AF-1 for Human Islet Isolation.Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes: a Consensus Report on the Igls Criteria from the IPITA/EPITA Opinion Leaders Workshop.Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation.
P2860
Q26822596-82F07A9B-BF5D-40B0-9610-D7975B7005E8Q33610710-40FFCE13-85C8-4373-AF86-53108E9E78CFQ34026630-283AB0D5-C985-4FCF-8FBB-E23EA6F6D41BQ34356000-BC1B7DDA-3CD1-42BC-8CD6-8DC06A2726D8Q34976218-57D0B215-205A-45A5-9437-732FCB77857EQ35123321-30B6AEEB-19F6-4B2C-98DD-763C7E41F4E7Q35558866-1C70D813-672D-48EF-B472-2B9C9382FB7FQ36955936-47BC9972-20BE-4056-9FB8-AA201D75147DQ37108880-A5DB7F19-2521-4EAD-A979-5395A2779147Q37357372-C04A3ED8-0890-421E-95B6-DAEB550969EBQ37381194-29C9A957-64F5-4923-93B7-90A9776E4630Q40287595-1D639909-0155-4C79-92D4-352DD9653754Q40542228-3437C464-B953-4DA3-832C-E9665B0A2D3BQ40967741-5161AC5A-AE08-4174-A996-55FECF2DB094Q41769630-A0EB37E7-B39E-4375-BF4C-DCC0DE6F9659Q41815343-FC3B2B17-D850-4F5D-8D7C-13B080D8707FQ42451662-A88D214F-E768-4C59-A4E1-331C934CA4F7Q42778505-6DB6CFA6-B6DA-41F5-B0C6-467C5F3C042FQ43225003-408F7700-F507-4A84-B0D0-D4362C742A87Q43272454-20688135-19CB-4881-A4A2-3B4C0CF9ED9CQ47292885-6ED19B6B-F13D-4ED9-94FD-A4AEA44013BFQ49906467-48B210F0-9190-4FF3-89AC-5318CB1FEF8CQ51328144-9B1A604A-1EAC-44AB-A035-5CF8DF527503
P2860
Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
@en
Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
@nl
type
label
Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
@en
Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
@nl
prefLabel
Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
@en
Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
@nl
P2093
P2860
P50
P1476
Simple measures to monitor beta-cell mass and assess islet graft dysfunction.
@en
P2093
Alejandro R
Faradji RN
Messinger S
P2860
P304
P356
10.1111/J.1600-6143.2006.01620.X
P407
P577
2006-12-06T00:00:00Z